rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1999-7-8
|
pubmed:abstractText |
To evaluate the effectiveness and the safety of danaparoid sodium in the treatment of critically ill patients with standard unfractionated heparin-induced thrombocytopenia (HIT) or low-molecular-weight HIT.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0012-3692
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
115
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1616-20
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10378558-Adult,
pubmed-meshheading:10378558-Aged,
pubmed-meshheading:10378558-Aged, 80 and over,
pubmed-meshheading:10378558-Anticoagulants,
pubmed-meshheading:10378558-Aspirin,
pubmed-meshheading:10378558-Blood Coagulation Factors,
pubmed-meshheading:10378558-Chondroitin Sulfates,
pubmed-meshheading:10378558-Critical Illness,
pubmed-meshheading:10378558-Dermatan Sulfate,
pubmed-meshheading:10378558-Drug Therapy, Combination,
pubmed-meshheading:10378558-Female,
pubmed-meshheading:10378558-Fibrinolytic Agents,
pubmed-meshheading:10378558-Follow-Up Studies,
pubmed-meshheading:10378558-Heparin,
pubmed-meshheading:10378558-Heparitin Sulfate,
pubmed-meshheading:10378558-Humans,
pubmed-meshheading:10378558-Injections, Subcutaneous,
pubmed-meshheading:10378558-Male,
pubmed-meshheading:10378558-Middle Aged,
pubmed-meshheading:10378558-Platelet Aggregation Inhibitors,
pubmed-meshheading:10378558-Platelet Count,
pubmed-meshheading:10378558-Recurrence,
pubmed-meshheading:10378558-Retrospective Studies,
pubmed-meshheading:10378558-Safety,
pubmed-meshheading:10378558-Thrombocytopenia,
pubmed-meshheading:10378558-Treatment Outcome
|
pubmed:year |
1999
|
pubmed:articleTitle |
Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia.
|
pubmed:affiliation |
Department of Hematology, Hopital Nord CHRU, Saint-Etienne, France.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|